PPIA and neoplasm: Fascinatingly, as part of a multicentre single-arm clinical trial investigating MM resistance (NCT040065789), Cohen et al recently reported that either PPIA/CYPA knockout or inhibition using CsA sensitised resistant MM tumour cells to proteosome inhibition, further underscoring the potential clinical impact of CYPA inhibition (Cohen et al, 2021).